technetium tc 99m hydroxymethylene diphosphonate has been researched along with deoxypyridinoline in 1 studies
| Studies (technetium tc 99m hydroxymethylene diphosphonate) | Trials (technetium tc 99m hydroxymethylene diphosphonate) | Recent Studies (post-2010) (technetium tc 99m hydroxymethylene diphosphonate) | Studies (deoxypyridinoline) | Trials (deoxypyridinoline) | Recent Studies (post-2010) (deoxypyridinoline) |
|---|---|---|---|---|---|
| 618 | 35 | 87 | 1,364 | 261 | 143 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayabuchi, N; Hiromatsu, Y; Ishibashi, M; Kurata, S; Nishida, H | 1 |
1 trial(s) available for technetium tc 99m hydroxymethylene diphosphonate and deoxypyridinoline
| Article | Year |
|---|---|
A clinical assessment of the relationship between bone scintigraphy and serum biochemical markers in hemodialysis patients.
Topics: Adult; Aged; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Radionuclide Imaging; Radiopharmaceuticals; Renal Dialysis; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Technetium Tc 99m Medronate | 2004 |